Multiple sclerosis (MS) is a chronic disease of the central nervous system, affecting the brain, spinal cord, and optic nerves. It is an immune-mediated disease, meaning that the body’s immune system mistakenly attacks healthy tissue. In MS, the primary target is myelin, the protective coating that surrounds nerve fibres. Damage to myelin disrupts the transmission of nerve signals, leading to a wide range of neurological symptoms.
This article provides an evidence based overview of multiple sclerosis based on current scientific knowledge. It is intended for educational purposes and should not replace advice from a qualified healthcare professional.
What causes MS?
Despite decades of research, there is no single known cause of MS. Scientists believe it develops through a combination of genetic susceptibility and environmental factors.
Research has identified several factors associated with an increased risk of developing MS, including:
• Infection with the Epstein–Barr virus (EBV), particularly infectious mononucleosis.
• Low vitamin D levels and reduced sunlight exposure.
• Smoking.
• Obesity during adolescence.
• Certain genetic variations that influence immune function.
Having one or more of these risk factors does not mean someone will develop MS, but together they may contribute to the disease process.
What happens in the brain?
In MS, immune cells cross the blood-brain barrier and attack myelin. This causes inflammation and creates areas of damage called lesions or plaques, which can be seen on MRI scans.
Over time, repeated inflammation may also damage the nerve fibres themselves (axons). While myelin can sometimes repair itself, this repair is often incomplete. As nerve damage accumulates, disability may gradually increase.
MS therefore involves both inflammation and neurodegeneration. Modern treatments are very effective at reducing inflammatory activity, but protecting and repairing nerve cells remains one of the greatest challenges in MS research.
Symptoms
No two people experience MS in exactly the same way. Symptoms depend on which parts of the nervous system are affected.
Common symptoms include:
• Fatigue, often the most disabling symptom.
• Problems with balance and coordination.
• Muscle weakness or stiffness.
• Numbness or tingling.
• Vision problems, including optic neuritis.
• Walking difficulties.
• Bladder and bowel problems.
• Cognitive changes affecting memory, concentration, or processing speed.
• Pain.
• Speech and swallowing difficulties.
Symptoms may fluctuate, improve, or gradually worsen over time.
Types of MS
MS is usually classified into three main forms.
Relapsing-remitting MS (RRMS) is the most common type. People experience relapses (new or worsening symptoms) followed by periods of partial or complete recovery.
Secondary progressive MS (SPMS) develops in some people who initially have relapsing-remitting MS. Disability gradually worsens over time, with or without relapses.
Primary progressive MS (PPMS) involves gradual worsening of symptoms from the beginning, without distinct relapses. Approximately 10–15% of people with MS have this form.
Diagnosis
There is no single test that confirms MS. Diagnosis combines several pieces of evidence, including:
• A neurological examination.
• MRI scans of the brain and spinal cord.
• Lumbar puncture to analyse cerebrospinal fluid.
• Blood tests to exclude other conditions.
• Evoked potential tests in selected cases.
Doctors use internationally recognised diagnostic criteria to demonstrate that damage has occurred in different parts of the central nervous system at different times.
Treatment
Although there is currently no cure for MS, treatment has improved dramatically over the past two decades.
Disease-modifying therapies (DMTs) reduce immune attacks and can significantly lower relapse rates while slowing disease progression in many people. Some highly effective therapies can reduce inflammatory activity by more than 90%.
Treatment also focuses on managing symptoms through:
• Physiotherapy.
• Occupational therapy.
• Speech and language therapy.
• Regular exercise.
• Fatigue management.
• Pain control.
• Psychological support.
Many people with MS continue to work, raise families, and lead active lives for many years after diagnosis.
The future of MS treatment
Research is advancing rapidly.
Researchers are investigating treatments that may repair myelin, protect nerve cells from damage, and restore normal immune function. CAR T-cell therapy is an experimental treatment currently being studied in clinical trials. Early research is encouraging, but it has not yet been proven to be safe and effective for routine treatment of MS.
Autologous haematopoietic stem cell transplantation (AHSCT) has shown impressive results in carefully selected people with highly active inflammatory MS. However, it is not considered a cure and is not appropriate for everyone. The treatment carries significant risks and should only be performed in specialised centres.
Researchers are also developing blood biomarkers that may improve diagnosis and help predict disease activity, allowing treatment to become more personalised.
Another major focus of research is remyelination—the repair of damaged myelin. While no remyelination therapy has yet been approved for MS, this is one of the most promising areas of current research and offers hope that future treatments may restore lost function rather than simply slowing disease progression.
Living with MS
MS affects each person differently. Some people experience only mild symptoms throughout their lives, while others develop significant disability. Because of this variability, treatment decisions should always be individualised.
Advances in MRI, medications, rehabilitation, and scientific understanding have transformed the outlook for many people with MS. Earlier diagnosis and earlier treatment are helping many patients maintain their independence for longer than was possible just a generation ago.
Although challenges remain, the pace of research has never been greater. Our growing understanding of the immune system, genetics, nerve repair, and personalised medicine provides genuine reason for optimism. While there is still no cure, scientists around the world are working towards treatments that not only control MS more effectively but may one day prevent, halt, or even reverse some of its effects.